Accounting for Oral Corticosteroids Tapering and Reduction in Adverse Effect Burden in Health Economic Evaluations: External Assessment Group Perspective

Julia Whitehall; Lakshmi Jayachandran; Najmeh Moradi; Katie Thomson; Madeleine Still; Sheila A. Wallace; Ayomikun Ogunyemi; Gurdeep S. Sagoo; Gill Norman; Stephen Rice

doi:10.1007/s40273-026-01617-0

Accounting for Oral Corticosteroids Tapering and Reduction in Adverse Effect Burden in Health Economic Evaluations: External Assessment Group Perspective

Julia Whitehall
, Lakshmi Jayachandran
, Najmeh Moradi
, Katie Thomson
, Madeleine Still
, Sheila A. Wallace
, Ayomikun Ogunyemi
, Gurdeep S. Sagoo
, Gill Norman
, Stephen Rice

Newcastle University

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	1145-1149
Number of pages	5
Journal	PharmacoEconomics
Volume	44
Issue number	9
DOIs	https://doi.org/10.1007/s40273-026-01617-0
State	Accepted/In press - 2026
Externally published	Yes

ASJC Scopus Subject Areas

Pharmacology
Health Policy
Public Health, Environmental and Occupational Health

Access to Document

10.1007/s40273-026-01617-0

Cite this

Whitehall, J., Jayachandran, L., Moradi, N., Thomson, K., Still, M., Wallace, S. A., Ogunyemi, A., Sagoo, G. S., Norman, G., & Rice, S. (Accepted/In press). Accounting for Oral Corticosteroids Tapering and Reduction in Adverse Effect Burden in Health Economic Evaluations: External Assessment Group Perspective. PharmacoEconomics, 44(9), 1145-1149. https://doi.org/10.1007/s40273-026-01617-0

Whitehall, J, Jayachandran, L, Moradi, N, Thomson, K, Still, M, Wallace, SA, Ogunyemi, A, Sagoo, GS, Norman, G & Rice, S 2026, 'Accounting for Oral Corticosteroids Tapering and Reduction in Adverse Effect Burden in Health Economic Evaluations: External Assessment Group Perspective', PharmacoEconomics, vol. 44, no. 9, pp. 1145-1149. https://doi.org/10.1007/s40273-026-01617-0

@article{b53e0f4235204afe986f75a3d80576f9,

title = "Accounting for Oral Corticosteroids Tapering and Reduction in Adverse Effect Burden in Health Economic Evaluations: External Assessment Group Perspective",

author = "Julia Whitehall and Lakshmi Jayachandran and Najmeh Moradi and Katie Thomson and Madeleine Still and Wallace, \{Sheila A.\} and Ayomikun Ogunyemi and Sagoo, \{Gurdeep S.\} and Gill Norman and Stephen Rice",

year = "2026",

doi = "10.1007/s40273-026-01617-0",

language = "English",

volume = "44",

pages = "1145--1149",

journal = "PharmacoEconomics",

issn = "1170-7690",

publisher = "Adis International Ltd.",

number = "9",

}

TY - JOUR

T1 - Accounting for Oral Corticosteroids Tapering and Reduction in Adverse Effect Burden in Health Economic Evaluations

T2 - External Assessment Group Perspective

AU - Whitehall, Julia

AU - Jayachandran, Lakshmi

AU - Moradi, Najmeh

AU - Thomson, Katie

AU - Still, Madeleine

AU - Wallace, Sheila A.

AU - Ogunyemi, Ayomikun

AU - Sagoo, Gurdeep S.

AU - Norman, Gill

AU - Rice, Stephen

PY - 2026

Y1 - 2026

UR - https://www.scopus.com/pages/publications/105037483376

UR - https://www.scopus.com/pages/publications/105037483376#tab=citedBy

U2 - 10.1007/s40273-026-01617-0

DO - 10.1007/s40273-026-01617-0

M3 - Letter

C2 - 42056679

AN - SCOPUS:105037483376

SN - 1170-7690

VL - 44

SP - 1145

EP - 1149

JO - PharmacoEconomics

JF - PharmacoEconomics

IS - 9

ER -

Accounting for Oral Corticosteroids Tapering and Reduction in Adverse Effect Burden in Health Economic Evaluations: External Assessment Group Perspective

ASJC Scopus Subject Areas

Access to Document

Other files and links

Cite this